We are live on
!
Find out more
Neuberger Berman Group Portfolio holdings
AUM
$150B
1-Year Est. Return
40.08%
This Fund
S&P 500
This Quarter
Est. Return
+3.72%
1 Year Est. Return
+40.08%
3 Year Est. Return
+113.08%
5 Year Est. Return
+141.06%
10 Year Est. Return
+565.4%
AUM
$134B
AUM Growth
-$2.51B
(-1.8%)
Cap. Flow
-$4.46B
Cap. Flow
% of AUM
-3.32%
Top 10 Holdings %
Top 10 Hldgs %
24%
Holding
2,213
New
182
Increased
966
Reduced
894
Closed
102
Avg Time Held Equity + Options
22.2
quarters
Top 10 Avg Time Held Equity + Options
23.8
quarters
Top 20 Avg Time Held Equity + Options
19
quarters
Avg Time Held Equity only
22.3
quarters
Top 10 Avg Time Held Equity only
23.8
quarters
Top 20 Avg Time Held Equity only
19
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Neuberger Core Equity ETF
NBCR
|
+$190M |
| 2 |
United Rentals
URI
|
+$166M |
| 3 |
Constellation Energy
CEG
|
+$147M |
| 4 |
UGI
UGI
|
+$134M |
| 5 |
Celestica
CLS
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$246M |
| 2 |
S&P Global
SPGI
|
+$201M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$197M |
| 4 |
Aon
AON
|
+$184M |
| 5 |
JPMorgan Chase
JPM
|
+$172M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.15% |
| 2 | Financials | 14.23% |
| 3 | Industrials | 11.32% |
| 4 | Healthcare | 9.42% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2051
JetBlue
JBLU
$1.45B
| $46.5K | ﹤0.01% |
10,219
| – | – |
2023 Q4
8 quarters
|
|
2052
Erasca
ERAS
$5.61B
| $46K | ﹤0.01% |
12,358
+1,253
| +11% | +$3.52K |
2024 Q4
4 quarters
|
|
2053
Tronox
TROX
$580M
| $44.3K | ﹤0.01% |
+10,635
| New | +$40.5K |
2025 Q4
0 quarters
|
|
2054
Sana Biotechnology
SANA
$835M
| $43.7K | ﹤0.01% |
10,746
-432
| -4% | -$1.93K |
2025 Q1
3 quarters
|
|
2055
Ready Capital
RC
$215M
| $42.8K | ﹤0.01% |
19,632
+9,222
| +89% | +$25.8K |
2025 Q1
3 quarters
|
|
2056
Pacific Biosciences
PACB
$724M
| $40.1K | ﹤0.01% |
+21,435
| New | +$41.2K |
2025 Q4
0 quarters
|
|
2057
Braemar Hotels & Resorts
BHR
$83.1M
| $39.5K | ﹤0.01% |
+13,756
| New | +$37.1K |
2025 Q4
0 quarters
|
|
2058
Gossamer Bio
GOSS
$56.9M
| $38.9K | ﹤0.01% |
+157
| New | +$35.8K |
2025 Q4
0 quarters
|
|
2059
DELISTED
Talkspace
TALK
| $38.2K | ﹤0.01% |
+10,528
| New | +$33.4K |
2025 Q4
0 quarters
|
|
2060
Prime Medicine
PRME
$724M
| $37.9K | ﹤0.01% |
+10,915
| New | +$48.6K |
2025 Q4
0 quarters
|
|
2061
Vaalco Energy
EGY
$632M
| $37.7K | ﹤0.01% |
10,351
-106
| -1% | -$392 |
2024 Q2
6 quarters
|
|
2062
Xerox
XRX
$361M
| $36.5K | ﹤0.01% |
+15,409
| New | +$45.6K |
2025 Q4
0 quarters
|
|
2063
Maravai LifeSciences
MRVI
$1.11B
| $36.4K | ﹤0.01% |
+11,193
| New | +$37.7K |
2025 Q4
0 quarters
|
|
|
SVC
2064
Service Properties Trust
SVC
$926M
| $35.7K | ﹤0.01% |
3,878
+1,025
| +36% | +$10.3K |
2024 Q4
4 quarters
|
|
2065
Hyliion Holdings
HYLN
$686M
| $33.8K | ﹤0.01% |
18,392
+1,028
| +6% | +$2.07K |
2025 Q3
1 quarter
|
|
2066
Coty
COTY
$2.51B
| $33.3K | ﹤0.01% |
10,813
-13,479
| -55% | -$49K |
2024 Q4
4 quarters
|
|
2067
Cocrystal Pharma
COCP
$20.6M
| $31.2K | ﹤0.01% |
31,886
| – | – |
2025 Q3
1 quarter
|
|
2068
enCore Energy
EU
$188M
| $31.2K | ﹤0.01% |
+12,571
| New | +$35.9K |
2025 Q4
0 quarters
|
|
2069
SmartRent
SMRT
$224M
| $30.2K | ﹤0.01% |
+14,937
| New | +$24.5K |
2025 Q4
0 quarters
|
|
2070
Quantum-Si Incorporated
QSI
$335M
| $29.5K | ﹤0.01% |
+26,820
| New | +$43.7K |
2025 Q4
0 quarters
|
|
2071
Definitive Healthcare
DH
$105M
| $29.3K | ﹤0.01% |
+10,217
| New | +$28.3K |
2025 Q4
0 quarters
|
|
2072
DocGo
DCGO
$33.5M
| $29.1K | ﹤0.01% |
+33,154
| New | +$35.4K |
2025 Q4
0 quarters
|
|
2073
Clover Health Investments
CLOV
$2.54B
| $28.6K | ﹤0.01% |
12,185
+1,985
| +19% | +$5.43K |
2025 Q3
1 quarter
|
|
2074
Cerus
CERS
$464M
| $28.6K | ﹤0.01% |
13,874
+1,187
| +9% | +$2.06K |
2024 Q2
6 quarters
|
|
2075
New Fortress Energy
NFE
$24.9M
| $28.3K | ﹤0.01% |
496
-11
| -2% | -$811 |
2022 Q4
12 quarters
|
|
Similar funds
Neuberger Berman Group's Q4 2025 Portfolio in Review
As of Q4 2025, Neuberger Berman Group held 2,213 positions worth $134B, down 1.8% from $137B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Neuberger Berman Group withdrew a net $4.46B in Q4 2025, closing 102 positions and reducing 894 holdings. Its most notable exit was Verona Pharma, an estimated $36M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Financials and Industrials.
Against the trend, Neuberger Berman Group opened a new position in BillionToOne Inc worth $57.4M.
- Neuberger Berman Group's largest Q4 2025 buy was BillionToOne Inc: 700,867 shares worth $57.4M.
- Neuberger Berman Group added most to Neuberger Core Equity ETF in Q4 2025, an estimated $190M increase.
- Neuberger Berman Group's biggest Q4 2025 reduction was Sandisk, cutting an estimated $246M.
- Neuberger Berman Group fully exited Verona Pharma in Q4 2025, selling an estimated $36M.
- Neuberger Berman Group's ten largest holdings make up 24% of its $134B portfolio in Q4 2025.
- Neuberger Berman Group opened 182 new positions and closed 102 in Q4 2025.
- Neuberger Berman Group's portfolio value fell 1.8% quarter-over-quarter to $134B.
Based on Neuberger Berman Group's 13F filing for Q4 2025, filed 13 Feb 2026.